NEW YORK--(BUSINESS WIRE)--April 5, 2006--Xenomics, Inc. (OTCBB:XNOM - News; FWB:XE7), a developer of next-generation DNA diagnostic technologies, has appointed Colin J. Foster, former CEO and President of Bayer Pharmaceuticals Corporation & Regional Head of North American Pharmaceutical Operations, to its Board of Directors.
